About: An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2012 (fr) наукова стаття, опублікована в лютому 2012 (uk) im Februar 2012 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q56775297-63AED9F7-2B90-48C2-87F6-025C704855F3
publication date	2012-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56775297-4816E8D6-7C36-44BB-9A2E-51CC24B34FCF
language of work or name	English
exact match	wds:Q56775297-399ACF94-5E01-4184-962A-D2B22032532F
exact match	https://scigraph.springernature.com/pub.10.1007/s00280-011-1728-3
cites work	wds:Q56775297-062F50CF-50BA-46EC-96B0-3005910F1558 wds:Q56775297-066E7739-571E-409A-9DB1-604FC890AFF5 wds:Q56775297-17F1264A-5CD8-4FD2-9E9C-6D9884DAA7E9 wds:Q56775297-1C2A0258-7AC5-4C19-B90D-D21C647E20AE wds:Q56775297-284D61BE-1B0E-427A-94AF-6BDB2D680F71 wds:Q56775297-28C9AFD9-2F41-450E-B14D-8DB880596D80 wds:Q56775297-36CD3BE1-F10F-4335-A35A-CA55C191F5D8 wds:Q56775297-3D567D13-93E6-44A4-9577-F251B07B5B2C wds:Q56775297-44B4BB59-DE97-4B9B-8C7F-FF2E99994B68 wds:Q56775297-46E4B67A-155F-493B-AD6E-98DAC00E157F wds:Q56775297-46FCC79D-7144-4E3B-ADCA-039960ED251D wds:Q56775297-53C0B8E6-7713-4087-9249-CA712C001CE7 wds:Q56775297-56939DA6-B0AC-43EF-BAA7-FC2D6CABBCB3 wds:Q56775297-631E77F4-EFDB-4B4D-A995-B05F37001CA8 wds:Q56775297-7BF248DE-4C29-4FE0-A8EA-70421E3E111B wds:Q56775297-92664B3F-C7FE-4B3A-B78B-7D5528D19FC7 wds:Q56775297-98FCB004-CDA2-4E7A-810B-FE7E09C0E110 wds:Q56775297-A15A42C0-C3FF-4D19-9F7A-B5A26EB41A82 wds:Q56775297-AA94BEDE-D9E8-42FE-A373-BED1207E3C6A wds:Q56775297-BCBF2F4E-675E-4D6B-8B8F-166C27DF13C0 wds:Q56775297-C1B8424D-48F2-4BEF-935B-3CC6792270AF wds:Q56775297-C6F33899-5076-4419-9814-ECD97C99C618 wds:Q56775297-C9B0B3B8-0F2D-4A06-AF5F-8DDEBA876510 wds:Q56775297-D29B19BE-2719-4952-A98C-EA840CEC80DE wds:Q56775297-D3046149-C904-41C7-B0C5-94E3C5C0C1DC wds:Q56775297-D60B4760-9525-4CC0-8175-45B64BA574FA wds:Q56775297-DA08CF1A-ED0F-4608-8D5B-208B34FC6914 wds:Q56775297-DA52D635-E6B0-467E-B9AD-1E609A4D023E wds:Q56775297-DD57B140-F575-4079-95A3-11C3629BC5F0 wds:Q56775297-E46EC6EC-2E6C-48D7-ADD4-036576C356C5 wds:Q56775297-EF8D14CD-BB0C-46EB-B96E-FBDA24B4E2C8 wds:Q56775297-F78A5AE3-3D38-4C4B-AF29-36195A16D997 wds:Q56775297-FA6A4CB0-36DF-4BBA-A63A-9520DC3C4ABC
cites work	Is breast cancer survival improving? Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects. Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer Capecitabine and cisplatin combination is an active and well-tolerated doublet in the treatment of metastatic breast carcinoma patients pretreated with anthracycline and taxanes Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes. Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer Lapatinib plus capecitabine for HER2-positive advanced breast cancer Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study. Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer Randomized Phase II Trial of Letrozole and Letrozole Plus Low-Dose Metronomic Oral Cyclophosphamide As Primary Systemic Treatment in Elderly Breast Cancer Patients Patient preferences for oral versus intravenous palliative chemotherapy Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer. A Phase II study of capecitabine and vinorelbine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes. A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer Phase II study of capecitabine plus trastuzumab in human epidermal growth factor receptor 2 overexpressing metastatic breast cancer pretreated with anthracyclines or taxanes. Capecitabine and vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxane Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer Gemcitabine/capecitabine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes Daily low-dose/continuous capecitabine combined with neo-adjuvant irradiation reduces VEGF and PDGF-BB levels in rectal carcinoma patients. Phase II study of an 'all-oral' regimen of capecitabine, idarubicin and cyclophosphamide for metastatic breast cancer--safety, efficacy and quality of life Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study Gemcitabine plus capecitabine combination in metastatic breast cancer patients previously treated with anthracyclines and taxanes Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: a phase II study Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines
author name string	wds:Q56775297-417239AA-ED24-4594-A9E3-DE744AA51C2D wds:Q56775297-698376E9-255E-44C6-867A-3E32FDFB9F67 wds:Q56775297-7ED60173-2294-48A5-8118-A599DBE13B1A wds:Q56775297-8AEF2ECB-BEEE-4FC3-8968-7AA28D928430 wds:Q56775297-9EEC82DF-9DB0-43F0-83E0-ED736D83E6E9 wds:Q56775297-A8BAFED1-68D4-4A06-8A8F-90698D1170D9 wds:Q56775297-AC7207E8-41B4-4D0A-AB6B-78EF730CFEBA
author name string	Zhonghua Wang Zhimin Shao Jialei Wang Xichun Hu Jingsong Lu Xiaonan Hong Shiangjiin Leaw
rdfs:label	An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study (en) An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study (nl)
skos:prefLabel	An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study (en) An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study (nl)
name	An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study (en) An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study (nl)
title	wds:Q56775297-16A1C609-51AF-4536-9E00-1A06D6C41D64
title	An all-oral combination of metronomic cyclophosphamide plus capecitabine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: a phase II study (en)
page(s)	wds:Q56775297-274897FF-51DE-4F23-9069-ACA54EA99A9C

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software